RhyGaze
RhyGaze is a biotechnology company developing gene therapies for retinal diseases causing blindness. Founded on research from the Institute of Molecular and Clinical Ophthalmology Basel, the company aims to restore vision using a novel optogenetic approach. This Series A funding will support clinical trials of their lead candidate.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $86M
Date: 10-Jan-2025
Investors: GV (Google Ventures), Arch Venture Partners, F-Prime Capital, BioGeneration Ventures, Novartis Venture Fund
Markets: Biotechnology, Gene Therapy, Ophthalmology, HealthTech
HQ: Basel, Basel-Stadt, Switzerland
Founded: 2024
Website: https://rhygaze.com/en/
LinkedIn: https://www.linkedin.com/company/rhygaze-ag
Crunchbase: https://www.crunchbase.com/organization/rhygaze
Leave a Comment
Comments
No comments yet.